These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 17154377

  • 1. Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison.
    Scaradavou A, Cunningham-Rundles S, Ho JL, Folman C, Doo H, Bussel JB.
    Am J Hematol; 2007 May; 82(5):335-41. PubMed ID: 17154377
    [Abstract] [Full Text] [Related]

  • 2. HIV-related thrombocytopenia.
    Scaradavou A.
    Blood Rev; 2002 Mar; 16(1):73-6. PubMed ID: 11914001
    [Abstract] [Full Text] [Related]

  • 3. HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation.
    Landonio G, Galli M, Nosari A, Lazzarin A, Cipriani D, Crocchiolo P, Voltolin L, Giannelli F, Irato L, De Cataldo F.
    AIDS; 1990 Jan; 4(1):29-34. PubMed ID: 2156528
    [Abstract] [Full Text] [Related]

  • 4. Thrombocytopenia in HIV-infected drug users in the HAART era.
    Burbano X, Miguez MJ, Lecusay R, Rodriguez A, Ruiz P, Morales G, Castillo G, Baum M, Shor-Posner G.
    Platelets; 2001 Dec; 12(8):456-61. PubMed ID: 11798394
    [Abstract] [Full Text] [Related]

  • 5. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
    Papagianni A, Economou M, Tragiannidis A, Karatza E, Tsatra I, Gombakis N, Athanassiadou-Piperopoulou F, Athanasiou-Metaxa M.
    J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
    [Abstract] [Full Text] [Related]

  • 6. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM, Xu GX, Zhao YQ, Han SM, Shan YD.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
    Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey J, Reichman R, Erice A, Bucy RP, Kilby JM, Lederman MM, Hamilton CD, Lertora J, White BL, Tebas P, Duliege AM, Pollard RB, AIDS Clinical Trials Group 328 Study Team.
    Arch Intern Med; 2007 Mar 26; 167(6):597-605. PubMed ID: 17389292
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-6 and platelet protagonists in T lymphocyte and virological response.
    Miguez MJ, Rodríguez A, Hadrigan S, Asthana D, Burbano X, Fletcher MA.
    Platelets; 2005 Aug 26; 16(5):281-6. PubMed ID: 16011978
    [Abstract] [Full Text] [Related]

  • 10. [HIV-related thrombocytopenias].
    Mannucci PM, Gringeri A.
    Ann Ital Med Int; 2000 Aug 26; 15(1):20-7. PubMed ID: 10842888
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.
    AIDS; 2008 Aug 20; 22(13):1583-8. PubMed ID: 18670217
    [Abstract] [Full Text] [Related]

  • 14. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG.
    HIV Med; 2007 Jan 20; 8(1):46-54. PubMed ID: 17305932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study.
    Bruin M, Bierings M, Uiterwaal C, Révész T, Bode L, Wiesman ME, Kuijpers T, Tamminga R, de Haas M.
    Br J Haematol; 2004 Dec 20; 127(5):561-7. PubMed ID: 15566359
    [Abstract] [Full Text] [Related]

  • 17. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR, Swiss HIV Cohort Study.
    Clin Infect Dis; 2008 Oct 15; 47(8):1093-101. PubMed ID: 18783328
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP.
    Acta Paediatr Taiwan; 2006 Oct 15; 47(5):226-31. PubMed ID: 17352309
    [Abstract] [Full Text] [Related]

  • 19. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, James I, French MA.
    AIDS; 2007 Jul 31; 21(12):1525-34. PubMed ID: 17630546
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.